FDA clears Cymbalta to treat chronic musculoskeletal pain

Share this content:
The Food and Drug Administration recently approved Cymbalta (duloxetine hydrochloride) to treat chronic musculoskeletal pain, including discomfort from osteoarthritis and chronic lower back pain. The recommended dose for Cymbalta is a 60 milligram capsule taken once daily without regard to meals. The capsule should be swallowed whole, and not chewed, crushed or opened; the contents should never be sprinkled on food or mixed with liquids. Cymbalta was first used to treat major depressive disorder in 2004. Eli Lilly and Co. makes the medication.
http://www.cymbalta.com